Abciximab (previously known as c7E3 Fab), manufactured by Centocor and distributed by Eli Lilly under the trade name ReoPro®, is a platelet aggregation inhibitor mainly used during and after coronary artery procedures like angioplasty to prevent platelets from sticking together and causing thrombus (blood clot) formation within the coronary artery. Its mechanism of action is inhibition of glycoprotein IIb/IIIa.

GoldBamboo

... ABCIXIMAB (ReoPro®) prevents your blood from clotting during episodes of chest pain or a heart attack, or while you are undergoing a procedure to treat a blocked coronary artery. Generic abciximab injection is not yet available. ...
Drug Digest - more...

Image:Abciximab.png Abciximab Systematic (IUPAC) name Chimeric hum ...
Wikipedia - [full article]

Resources